🔎 Trials Near Me

Početna › Prekomjerna tjelesna masa › Kalifornija › Concord

Kliničke studije za Prekomjerna tjelesna masa u gradu Concord, CA

16 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u gradu Concord i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 2
  • John Muir Health - Concord /ID# 282469, Concord
  • Diablo Clinical Research /ID# 282530, Walnut Creek · 5 mi udaljenosti
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

U tijeku regrutacijaFaza 2
  • Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07720271

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

U tijeku regrutacijaFaza 3
  • Research Site, Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Research Site, Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Walnut Creek · 5 mi udaljenosti
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 do 75 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351045

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

U tijeku regrutacijaFaza 3
  • Diablo Clinical Research, Walnut Creek · 5 mi udaljenosti
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

U tijeku regrutacijaFaza 1
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 25. lip 2026. · NCT07607587

Studije za Prekomjerna tjelesna masa u drugim gradovima

Ostale studije u gradu Concord

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.